Clinical Research Detail Title Of Study An Open Label Randomized Controlled Phase II Study of AS1411 Combined With Cytarabine in the Treatment of Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia Disease Condition Patients with Primary refractory or relapsed AML Phase of Trial Phase-2 Discipline Oncology Start date of Trial 3/1/2010 Closing Date of Trial 3/1/2012 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]